Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2024 年第 1 季持倉
持倉截至 2024/3/31，2024/5/15 申報。只含多頭部位，變化是跟 2023 年第 4 季比股數。
- 持股檔數
- 87
- 較 2023 年第 4 季 +15
- 總值
- $28.1 億
- 較 2023 年第 4 季 +$1.99 億 (+7.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| FUSNFusion Pharmaceuticals Inc. | COM | 6,500,328 | $1.39 億 | 4.9% | 00.0% | 不變 | 歷史 |
| BSXBoston Scientific Corp | Stock | 1,956,000 | $1.34 億 | 4.8% | +66,000+3.5% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 2,985,190 | $1.23 億 | 4.4% | +730.0% | 加碼 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 226,000 | $9,019 萬 | 3.2% | +141,000+165.9% | 加碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 2,717,554 | $8,153 萬 | 2.9% | +1,500,000+123.2% | 加碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,005,000 | $7,962 萬 | 2.8% | −151,692−13.1% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 536,500 | $7,399 萬 | 2.6% | −121,500−18.5% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 803,300 | $7,347 萬 | 2.6% | −306,700−27.6% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 584,000 | $7,033 萬 | 2.5% | +94,881+19.4% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 2,695,000 | $6,891 萬 | 2.4% | +573,156+27.0% | 加碼 | 歷史 |
| CICigna Group | Stock | 184,500 | $6,701 萬 | 2.4% | +184,500 | 新進 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 502,000 | $6,624 萬 | 2.4% | +502,000 | 新進 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 68,000 | $6,545 萬 | 2.3% | 00.0% | 不變 | 歷史 |
| CGONCG Oncology, Inc. | COM | 1,454,765 | $6,386 萬 | 2.3% | +1,454,765 | 新進 | 歷史 |
| ILMNIllumina, Inc. | COM | 464,100 | $6,373 萬 | 2.3% | +464,100 | 新進 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 601,000 | $6,317 萬 | 2.2% | −270,000−31.0% | 減碼 | 歷史 |
| ALGNAlign Technology Inc | COM | 189,000 | $6,198 萬 | 2.2% | +33,200+21.3% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,412,500 | $5,742 萬 | 2.0% | −1,537,500−38.9% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 70,000 | $5,446 萬 | 1.9% | −15,000−17.6% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 217,000 | $4,985 萬 | 1.8% | −20,202−8.5% | 減碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,174,700 | $4,657 萬 | 1.7% | +1,174,700 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 933,500 | $4,359 萬 | 1.5% | +89,000+10.5% | 加碼 | 歷史 |
| CVSCVS Health Corp | Stock | 545,000 | $4,347 萬 | 1.5% | −195,000−26.4% | 減碼 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 1,445,000 | $4,310 萬 | 1.5% | +279,068+23.9% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 600,000 | $4,152 萬 | 1.5% | −110,000−15.5% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 227,000 | $4,134 萬 | 1.5% | −57,405−20.2% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 426,000 | $4,041 萬 | 1.4% | −189,000−30.7% | 減碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 668,300 | $3,748 萬 | 1.3% | −16,700−2.4% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 864,000 | $3,703 萬 | 1.3% | −216,000−20.0% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 243,000 | $3,632 萬 | 1.3% | +243,000 | 新進 | 歷史 |
| DHRDanaher Corp | Stock | 143,800 | $3,591 萬 | 1.3% | −146,200−50.4% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 799,700 | $3,509 萬 | 1.2% | −720,300−47.4% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 431,000 | $3,439 萬 | 1.2% | −28,400−6.2% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 710,000 | $3,057 萬 | 1.1% | −105,993−13.0% | 減碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 480,000 | $2,988 萬 | 1.1% | +100,000+26.3% | 加碼 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 5,785,352 | $2,974 萬 | 1.1% | −574,860−9.0% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 1,142,850 | $2,871 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,025,000 | $2,761 萬 | 1.0% | −694,103−40.4% | 減碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 1,300,064 | $2,739 萬 | 1.0% | +1,300,064 | 新進 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 384,893 | $2,558 萬 | 0.9% | +384,893 | 新進 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,800,000 | $2,475 萬 | 0.9% | −190,632−9.6% | 減碼 | 歷史 |
| DXCMDexcom Inc | COM | 176,900 | $2,454 萬 | 0.9% | +176,900 | 新進 | 歷史 |
| NGNENeurogene Inc. | COM | 465,237 | $2,368 萬 | 0.8% | −1,006−0.2% | 減碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 760,000 | $2,231 萬 | 0.8% | +760,000 | 新進 | 歷史 |
| IMNMImmunome Inc. | COM | 873,891 | $2,157 萬 | 0.8% | −459,588−34.5% | 減碼 | 歷史 |
| TMOThermo Fisher Scientific Inc. | Stock | 36,600 | $2,127 萬 | 0.8% | −146,000−80.0% | 減碼 | 歷史 |
| GKOSGLAUKOS Corp | COM | 224,000 | $2,112 萬 | 0.8% | +224,000 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 635,000 | $2,047 萬 | 0.7% | +575,000+958.3% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 284,000 | $1,940 萬 | 0.7% | −286,137−50.2% | 減碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 286,400 | $1,862 萬 | 0.7% | −13,800−4.6% | 減碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,735,000 | $1,843 萬 | 0.7% | +13,420+0.8% | 加碼 | 歷史 |
| MCKMcKesson Corp | Stock | 33,300 | $1,788 萬 | 0.6% | −52,200−61.1% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 383,500 | $1,654 萬 | 0.6% | +383,500 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 505,000 | $1,632 萬 | 0.6% | +260,000+106.1% | 加碼 | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 764,200 | $1,497 萬 | 0.5% | −522,800−40.6% | 減碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 384,245 | $1,447 萬 | 0.5% | +384,245 | 新進 | 歷史 |
| Cybin Ord23256X100 | COM | 34,884,000 | $1,442 萬 | 0.5% | +34,884,000 | 新進 | – |
| COLLCollegium Pharmaceutical, Inc | COM | 361,400 | $1,403 萬 | 0.5% | +370.0% | 加碼 | 歷史 |
| PRMEPrime Medicine, Inc. | COM | 1,990,000 | $1,393 萬 | 0.5% | +1,990,000 | 新進 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 209,700 | $1,388 萬 | 0.5% | +209,700 | 新進 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 982,000 | $1,382 萬 | 0.5% | +982,000 | 新進 | 歷史 |
| ACIUAC Immune SA | SHS | 4,470,000 | $1,323 萬 | 0.5% | +9200.0% | 加碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 8,298,570 | $1,253 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 8,902,972 | $1,175 萬 | 0.4% | +8,902,972 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 166,000 | $1,164 萬 | 0.4% | +166,000 | 新進 | 歷史 |
| RDNTRadNet, Inc. | COM | 238,000 | $1,158 萬 | 0.4% | +238,000 | 新進 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 225,000 | $1,145 萬 | 0.4% | +225,000 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 475,000 | $1,123 萬 | 0.4% | +475,000 | 新進 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 588,500 | $1,088 萬 | 0.4% | +588,500 | 新進 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 160,000 | $1,084 萬 | 0.4% | +160,000 | 新進 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,673,538 | $895.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 130,000 | $563.5 萬 | 0.2% | +130,000 | 新進 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,221,555 | $510.6 萬 | 0.2% | −133,445−9.8% | 減碼 | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 202,333 | $502.6 萬 | 0.2% | +202,333 | 新進 | 歷史 |
| EBSEmergent BioSolutions Inc. | COM | 1,908,000 | $482.7 萬 | 0.2% | +1,908,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 5,026,000 | $453.1 萬 | 0.2% | +5460.0% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 75,000 | $410.2 萬 | 0.1% | −1,073,308−93.5% | 減碼 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,150,000 | $373.8 萬 | 0.1% | +10,000+0.9% | 加碼 | 歷史 |
| DNAGinkgo Bioworks Holdings, Inc. | CL A SHS | 3,000,000 | $348.0 萬 | 0.1% | +3,000,000 | 新進 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 2,413,000 | $335.4 萬 | 0.1% | +2,413,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 445,706 | $299.5 萬 | 0.1% | +445,706 | 新進 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 675,000 | $253.1 萬 | 0.1% | +675,000 | 新進 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,448,728 | $213.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KODKodiak Sciences Inc. | COM | 300,000 | $157.8 萬 | 0.1% | +300,000 | 新進 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,188,178 | $118.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COMM STK | 21,200 | $10.2 萬 | <0.1% | 00.0% | 不變依 1 比 30 拆股換算 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 89,543 | $2.71 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2023 年第 4 季之後清倉（17 檔）
2023 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 4 季股數 | 2023 年第 4 季市值 | 2023 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| KRTXKaruna Therapeutics, Inc. | COM | 206,000 | $6,520 萬 | 2.5% | 歷史 |
| IMGNImmunoGen, Inc. | COM | 1,829,215 | $5,424 萬 | 2.1% | 歷史 |
| ZTSZoetis Inc. | Stock | 240,000 | $4,737 萬 | 1.8% | 歷史 |
| HUMHumana Inc | Stock | 100,000 | $4,578 萬 | 1.8% | 歷史 |
| BDXBecton Dickinson & Co | Stock | 165,706 | $4,040 萬 | 1.5% | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 58,500 | $3,080 萬 | 1.2% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 714,000 | $2,185 萬 | 0.8% | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 529,000 | $1,882 萬 | 0.7% | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 780,900 | $1,552 萬 | 0.6% | 歷史 |
| AAgilent Technologies, Inc. | COM | 99,000 | $1,376 萬 | 0.5% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 447,434 | $1,364 萬 | 0.5% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 31,000 | $1,179 萬 | 0.5% | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 276,888 | $1,174 萬 | 0.4% | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 827,010 | $743.5 萬 | 0.3% | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 235,000 | $548.7 萬 | 0.2% | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 1,599,600 | $249.5 萬 | 0.1% | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 64,501 | $94.9 萬 | <0.1% | 歷史 |